
Anna Kathy Aman
Examiner (ID: 18092, Phone: (571)272-4515 , Office: P/2914 )
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2914, 2973 |
| Total Applications | 3318 |
| Issued Applications | 3249 |
| Pending Applications | 17 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15848079
[patent_doc_number] => 10639300
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-05
[patent_title] => Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists
[patent_app_type] => utility
[patent_app_number] => 16/090317
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9805
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090317
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090317 | Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists | Apr 11, 2017 | Issued |
Array
(
[id] => 15848079
[patent_doc_number] => 10639300
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-05
[patent_title] => Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists
[patent_app_type] => utility
[patent_app_number] => 16/090317
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9805
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090317
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090317 | Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists | Apr 11, 2017 | Issued |
Array
(
[id] => 15848079
[patent_doc_number] => 10639300
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-05
[patent_title] => Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists
[patent_app_type] => utility
[patent_app_number] => 16/090317
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9805
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090317
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090317 | Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists | Apr 11, 2017 | Issued |
Array
(
[id] => 11977435
[patent_doc_number] => 20170281589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'USE OF STING AGONISTS TO TREAT CHRONIC HEPATITIS B VIRUS INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/483645
[patent_app_country] => US
[patent_app_date] => 2017-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 9395
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15483645
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/483645 | Use of sting agonists to treat chronic hepatitis B virus infection | Apr 9, 2017 | Issued |
Array
(
[id] => 17266356
[patent_doc_number] => 11191760
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Compositions and methods for treating
[patent_app_type] => utility
[patent_app_number] => 16/091173
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8395
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091173
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091173 | Compositions and methods for treating | Apr 5, 2017 | Issued |
Array
(
[id] => 15360707
[patent_doc_number] => 20200016118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => HDAC INHIBITOR IN COMBINATION WITH VEGF/VEGFR INTERACTION FOR CANCER THERAPY BASED ON PLATELET COUNT
[patent_app_type] => utility
[patent_app_number] => 15/766197
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8350
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15766197
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/766197 | HDAC INHIBITOR IN COMBINATION WITH VEGF/VEGFR INTERACTION FOR CANCER THERAPY BASED ON PLATELET COUNT | Apr 4, 2017 | Abandoned |
Array
(
[id] => 12210979
[patent_doc_number] => 09907770
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-06
[patent_title] => 'Methods and compositions for increasing the anaerobic working capacity in tissues'
[patent_app_type] => utility
[patent_app_number] => 15/476620
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 27
[patent_no_of_words] => 11780
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15476620
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/476620 | Methods and compositions for increasing the anaerobic working capacity in tissues | Mar 30, 2017 | Issued |
Array
(
[id] => 11977491
[patent_doc_number] => 20170281645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'STEROID HORMONE PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/473733
[patent_app_country] => US
[patent_app_date] => 2017-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14817
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15473733
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/473733 | Steroid hormone pharmaceutical composition | Mar 29, 2017 | Issued |
Array
(
[id] => 15848077
[patent_doc_number] => 10639299
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-05
[patent_title] => Calcium sensing receptors, ligands, compositions, and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/090380
[patent_app_country] => US
[patent_app_date] => 2017-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 60
[patent_no_of_words] => 28114
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090380
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090380 | Calcium sensing receptors, ligands, compositions, and methods of use | Mar 28, 2017 | Issued |
Array
(
[id] => 16041007
[patent_doc_number] => 10682354
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-16
[patent_title] => Compositions and methods
[patent_app_type] => utility
[patent_app_number] => 16/090142
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8035
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090142 | Compositions and methods | Mar 27, 2017 | Issued |
Array
(
[id] => 16041007
[patent_doc_number] => 10682354
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-16
[patent_title] => Compositions and methods
[patent_app_type] => utility
[patent_app_number] => 16/090142
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8035
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090142 | Compositions and methods | Mar 27, 2017 | Issued |
Array
(
[id] => 13013863
[patent_doc_number] => 10030039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Anti-cancer agent and cancer cell killing method
[patent_app_type] => utility
[patent_app_number] => 15/468462
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 6656
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15468462
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/468462 | Anti-cancer agent and cancer cell killing method | Mar 23, 2017 | Issued |
Array
(
[id] => 11954578
[patent_doc_number] => 20170258729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'Pharmaceutical Formulations of a Bruton\'s Tyrosine Kinase Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 15/467414
[patent_app_country] => US
[patent_app_date] => 2017-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 52533
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15467414
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/467414 | Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor | Mar 22, 2017 | Abandoned |
Array
(
[id] => 11948166
[patent_doc_number] => 20170252318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'NOVEL THERAPEUTIC AGENT FOR ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/460846
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14337
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15460846
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/460846 | Therapeutic agent for Alzheimer's disease | Mar 15, 2017 | Issued |
Array
(
[id] => 12343338
[patent_doc_number] => 09949943
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Method for treating neurodegenerative diseases
[patent_app_type] => utility
[patent_app_number] => 15/459822
[patent_app_country] => US
[patent_app_date] => 2017-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6792
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15459822
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/459822 | Method for treating neurodegenerative diseases | Mar 14, 2017 | Issued |
Array
(
[id] => 11713486
[patent_doc_number] => 20170181985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'ELECTROSTATICALLY CHARGED NASAL APPLICATION METHOD AND PRODUCT FOR MICRO-FILTRATION'
[patent_app_type] => utility
[patent_app_number] => 15/458952
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4039
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15458952
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/458952 | Electrostatically charged nasal application method and product for micro-filtration | Mar 13, 2017 | Issued |
Array
(
[id] => 11961978
[patent_doc_number] => 20170266131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'Modulation of Macrophage Phenotype by Emodin'
[patent_app_type] => utility
[patent_app_number] => 15/458560
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14189
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15458560
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/458560 | Modulation of macrophage phenotype by emodin | Mar 13, 2017 | Issued |
Array
(
[id] => 11942013
[patent_doc_number] => 20170246164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'SMALL MOLECULES TARGETING ANDROGEN RECEPTOR NUCLEAR LOCALIZATION AND/OR LEVEL IN PROSTATE CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/457782
[patent_app_country] => US
[patent_app_date] => 2017-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14267
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15457782
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/457782 | Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer | Mar 12, 2017 | Issued |
Array
(
[id] => 11914163
[patent_doc_number] => 09782336
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-10
[patent_title] => 'Moisturizer and cosmetic containing same'
[patent_app_type] => utility
[patent_app_number] => 15/455528
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5235
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15455528
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/455528 | Moisturizer and cosmetic containing same | Mar 9, 2017 | Issued |
Array
(
[id] => 16197348
[patent_doc_number] => 10722484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => Methods of cancer treatment
[patent_app_type] => utility
[patent_app_number] => 16/083806
[patent_app_country] => US
[patent_app_date] => 2017-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 53
[patent_no_of_words] => 43222
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16083806
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/083806 | Methods of cancer treatment | Mar 8, 2017 | Issued |